Integrated network analyses for functional genomic studies in cancer

Seminars in Cancer Biology

Volumn 23, Issue 4, 2013, Pages 213-218

  Wilson, Jennifer L ^a   Hemann, Michael T ^b   Fraenkel, Ernest ^a   Lauffenburger, Douglas A ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Computational modeling; Regulatory networks; RNAi; Signaling pathways

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; COMPUTER MODEL; COMPUTER NETWORK; COPY NUMBER VARIATION; FUNCTIONAL GENOMICS; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ENGINEERING; GENETIC SCREENING; GENETIC VARIABILITY; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NONHUMAN; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84881104520     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.06.004     Document Type: Review

References (32)

1. Birmingham A., Selfors L.M., Forster T., Wrobel D., Kennedy C.J., Shanks E., et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 2009, 6(8):569-575.
2. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458(7239):719-724.
3. McLeod H.L. Cancer pharmacogenomics: early promise, but concerted effort needed. Science 2013, 339(6127):1563-1566.
4. Berger B., Peng J., Singh M. Computational solutions for omics data. Nat Rev Genet 2013, 14(5):333-346.
5. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339(6127):1546-1558.
6. Mohr S., Bakal C., Perrimon N. Genomic screening with RNAi: results and challenges. Annu Rev Biochem 2010, 79(1):37-64.
7. Kaelin W.G., Molecular biology. Use and abuse of RNAi to study mammalian gene function. Science 2012, 337(6093):421-422.
8. Vidal M., Cusick M.E., Barabási A.-L. Interactome networks and human disease. Cell 2011, 144(6):986-998.
9. Sigoillot F.D., King R.W. Vigilance and validation: keys to success in RNAi screening. ACS Chem Biol 2011, 6(1):47-60.
10. Pugh T.J., Weeraratne S.D., Archer T.C., Pomeranz Krummel D.A., Auclair D., Bochicchio J., et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 2012, 488(7409):106-110.
11. Jackson A.L., Linsley P.S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010, 9(57):1-11.
12. Adamson B., Smogorzewska A., Sigoillot F.D., King R.W., Elledge S.J. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol 2012, 14(3):318-328.
13. Zender L., Xue W., Zuber J., Semighini C.P., Krasnitz A., Ma B., et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008, 135(5):852-864.
14. Sigoillot F.D., Lyman S., Huckins J.F., Adamson B., Chung E., Quattrochi B., et al. A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens. Nature Methods 2012, 9(4):363-366.
15. Mesirov J., Garraway L. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. PNAS 2011, 108:12372-12377.
16. Hemann M.T., Fridman J.S., Zilfou J.T., Hernando E., Paddison P.J., Cordon-Cardo C., et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 2003, 33(3):396-400.
17. Wille L., Kemp M.L., Sandy P., Lewis C.L., Lauffenburger D.A. Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production. Mol Immunol 2007, 44(12):3085-3091.
18. Barabási A.-L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12(1):56-68.
19. Kholodenko B., Yaffe M.B., Kolch W. Computational approaches for analyzing information flow in biological networks. Sci Signal 2012, 5(220):re1.
20. Yaffe M.B. The scientific drunk and the lamppost: massive sequencing efforts in cancer discovery and treatment. Sci Signal 2013, 6(269):pe13-pe23.
21. Tentner A.R., Lee M.J., Ostheimer G.J., Samson L.D., Lauffenburger D.A., Yaffe M.B. Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress. Mol Syst Biol 2012, 8:1-18.
22. Wilson T.R., Fridlyand J., Yan Y., Penuel E., Burton L., Chan E., et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012, 487(7408):505-509.
23. Wagner J., Wolf-Yadlin A., Sevecka M., Grenier J., Root D., Lauffenburger D.A., et al. Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks. Sci Signal 2013, [in press].
24. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 2009, 5(5):e1000437.
25. Ravi D., Wiles A.M., Bhavani S., Ruan J., Leder P., Bishop A.J.R. A network of conserved damage survival pathways revealed by a genomic RNAi screen. PLoS Genet 2009, 5(6):e1000527.
26. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321(5897):1801-1806.
27. Kholodenko B., Yaffe M.B., Kolch W. Computational approaches for analyzing information flow in biological networks. Sci Signal 2012, 5(220).
28. Tran L.M., Bin Zhang, Zhang Z., Zhang C., Xie T., Lamb J., et al. Inferring causal genomic alterations in breast cancer using gene expression data. BMC Syst Biol 2011, 5(1):121.
29. Huang S.-S.C., Clarke D.C., Gosline S.J.C., Labadorf A., Chouinard C., Gordon W., et al. Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling. PLoS Comput Biol 2013, 9(2):e1002887.
30. Lee M.N., Roy M., Ong S.-E., Mertins P., Villani A., Li W., et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat Immunol 2012, 14(2):179-185.
31. Chen Y., Zhu J., Lum P.Y., Pinto S., MacNeil D.J., Zhang C., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008, 452(7186):429-435.
32. Gosline S.J.C., Spencer S., Orsu O., Fraenkel E. SAMNET: a network-based approach to integrate multi-dimensional high throughput datasets. Integr Biol 2012, 4(11):1415-1427.